Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share

v3.23.1
Net Loss Per Share
3 Months Ended
Mar. 31, 2023
Net Loss Per Share  
Net Loss Per Share

Note 2. Net Loss Per Share

 

Basic net loss per share is computed using the weighted-average number of common shares outstanding during the reporting period except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net loss per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options, warrants and convertible preferred shares (see Note 7. Stockholders’ Equity and Stock-Based Compensation). The common stock equivalents of performance-based milestone compensation arrangements are included as potentially dilutive shares only if the performance condition has been met as of the end of the reporting period.

 

The treasury stock method is used in calculating diluted net loss per share for potentially dilutive stock options and share purchase warrants, which assumes that any proceeds received from the exercise of in-the-money stock options and share purchase warrants would be used to purchase common shares at the average market price for the period, unless including the effects of these potentially dilutive securities would be anti-dilutive.

 

The following table sets forth the computation of the basic and diluted loss per share (dollars in millions, except share data):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2023

 

 

2022

 

Basic

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

Net loss attributable to common stockholders

 

$ (2.0 )

 

$ (2.0 )

Denominator:

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

11,673,736

 

 

 

10,283,280

 

Basic net loss per share

 

$ (0.17 )

 

$ (0.20 )

 

 

 

 

 

 

 

 

 

Diluted

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

Net loss attributable to common stockholders, basic

 

$ (2.0 )

 

$ (2.0 )

Effect of dilutive securities

 

 

 

 

 

 

Net loss, diluted

 

$ (2.0 )

 

$ (2.0 )

Denominator:

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - basic

 

 

 

 

 

 

 

 

Potential common share issuances:

 

 

11,673,736

 

 

 

10,283,280

 

Incremental dilutive shares from equity instruments (treasury stock method)

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

11,673,736

 

 

 

10,283,280

 

Diluted net loss per share

 

$ (0.17 )

 

$ (0.20 )

 

The following outstanding securities have been excluded from the computation of diluted weighted shares outstanding for the periods noted below, as they would have been anti-dilutive due to the Company’s losses for the three months ended March 31, 2023 and 2022 and also because the exercise price of certain of these outstanding securities was greater than the average closing price of the Company’s common stock.

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2023

 

 

2022

 

Warrants outstanding

 

 

 

 

 

45,577

 

Stock options outstanding

 

 

525,903

 

 

 

543,297

 

RSAs outstanding

 

 

416,316

 

 

 

188,588

 

Total

 

 

942,219

 

 

 

777,462